Why the study?
The combination of coronary artery disease and cancer is increasingly common, presenting a major clinical challenge despite advances in treating each condition individually.
The review highlights the complexity of managing concurrent CAD and cancer, emphasizing the growing role of percutaneous coronary intervention and polymer-free drug-eluting stents to facilitate timely oncological surgery.
Answers are grounded in this paper and cite their sources.
Concurrent CAD and cancer poses considerable management challenges; leaves open optimal integrated strategies.
Highlights The article presents an overview of the main studies on the treatment of patients with coronary artery disease and cancer. Abstract Cardiovascular and oncological diseases remain the leading causes of death globally. The combination of coronary artery disease and cancer is becoming more common in clinical practice. Despite the achievements in the treatment of both of these diseases separately, their combination is a considerable issue for specialists. This review article discusses the main issues of managing patients with cancer and coronary artery disease. Moreover, the article presents various treatment strategies, including simultaneous and step-by-step interventions, and shows the current trends of endovascular approach to the treatment of these patients.
No takes yet. Share an insight, caveat, or question.
Alekyan et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: